These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

528 related items for PubMed ID: 27530160

  • 1. The ACVR1 R206H mutation found in fibrodysplasia ossificans progressiva increases human induced pluripotent stem cell-derived endothelial cell formation and collagen production through BMP-mediated SMAD1/5/8 signaling.
    Barruet E, Morales BM, Lwin W, White MP, Theodoris CV, Kim H, Urrutia A, Wong SA, Srivastava D, Hsiao EC.
    Stem Cell Res Ther; 2016 Aug 17; 7(1):115. PubMed ID: 27530160
    [Abstract] [Full Text] [Related]

  • 2. Activin A amplifies dysregulated BMP signaling and induces chondro-osseous differentiation of primary connective tissue progenitor cells in patients with fibrodysplasia ossificans progressiva (FOP).
    Wang H, Shore EM, Pignolo RJ, Kaplan FS.
    Bone; 2018 Apr 17; 109():218-224. PubMed ID: 29170109
    [Abstract] [Full Text] [Related]

  • 3. Functional Testing of Bone Morphogenetic Protein (BMP) Pathway Variants Identified on Whole-Exome Sequencing in a Patient with Delayed-Onset Fibrodysplasia Ossificans Progressiva (FOP) Using ACVR1R206H -Specific Human Cellular and Zebrafish Models.
    Wentworth KL, Lalonde RL, Groppe JC, Brewer N, Moody T, Hansberry S, Taylor KE, Shore EM, Kaplan FS, Pignolo RJ, Yelick PC, Hsiao EC.
    J Bone Miner Res; 2022 Nov 17; 37(11):2058-2076. PubMed ID: 36153796
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of Wild-Type ACVR1 in Fibrodysplasia Ossificans Progressiva Mice Rescues Perinatal Lethality and Inhibits Heterotopic Ossification.
    Yamamoto M, Stoessel SJ, Yamamoto S, Goldhamer DJ.
    J Bone Miner Res; 2022 Nov 17; 37(11):2077-2093. PubMed ID: 35637634
    [Abstract] [Full Text] [Related]

  • 5. The Fibrodysplasia Ossificans Progressiva (FOP) mutation p.R206H in ACVR1 confers an altered ligand response.
    Hildebrand L, Stange K, Deichsel A, Gossen M, Seemann P.
    Cell Signal; 2017 Jan 17; 29():23-30. PubMed ID: 27713089
    [Abstract] [Full Text] [Related]

  • 6. Depletion of Mast Cells and Macrophages Impairs Heterotopic Ossification in an Acvr1R206H Mouse Model of Fibrodysplasia Ossificans Progressiva.
    Convente MR, Chakkalakal SA, Yang E, Caron RJ, Zhang D, Kambayashi T, Kaplan FS, Shore EM.
    J Bone Miner Res; 2018 Feb 17; 33(2):269-282. PubMed ID: 28986986
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The obligatory role of Activin A in the formation of heterotopic bone in Fibrodysplasia Ossificans Progressiva.
    Alessi Wolken DM, Idone V, Hatsell SJ, Yu PB, Economides AN.
    Bone; 2018 Apr 17; 109():210-217. PubMed ID: 28629737
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A.
    Hatsell SJ, Idone V, Wolken DM, Huang L, Kim HJ, Wang L, Wen X, Nannuru KC, Jimenez J, Xie L, Das N, Makhoul G, Chernomorsky R, D'Ambrosio D, Corpina RA, Schoenherr CJ, Feeley K, Yu PB, Yancopoulos GD, Murphy AJ, Economides AN.
    Sci Transl Med; 2015 Sep 02; 7(303):303ra137. PubMed ID: 26333933
    [Abstract] [Full Text] [Related]

  • 11. Activation of Gq signaling by Pasteurella multocida toxin inhibits the osteoblastogenic-like actions of Activin A in C2C12 myoblasts, a cell model of fibrodysplasia ossificans progressiva.
    Ebner JK, König GM, Kostenis E, Siegert P, Aktories K, Orth JHC.
    Bone; 2019 Oct 02; 127():592-601. PubMed ID: 31376533
    [Abstract] [Full Text] [Related]

  • 12. Molecular consequences of the ACVR1(R206H) mutation of fibrodysplasia ossificans progressiva.
    Song GA, Kim HJ, Woo KM, Baek JH, Kim GS, Choi JY, Ryoo HM.
    J Biol Chem; 2010 Jul 16; 285(29):22542-53. PubMed ID: 20463014
    [Abstract] [Full Text] [Related]

  • 13. Reduced GS Domain Serine/Threonine Requirements of Fibrodysplasia Ossificans Progressiva Mutant Type I BMP Receptor ACVR1 in the Zebrafish.
    Allen RS, Jones WD, Hale M, Warder BN, Shore EM, Mullins MC.
    J Bone Miner Res; 2023 Sep 16; 38(9):1364-1385. PubMed ID: 37329499
    [Abstract] [Full Text] [Related]

  • 14. Allele-Selective LNA Gapmers for the Treatment of Fibrodysplasia Ossificans Progressiva Knock Down the Pathogenic ACVR1R206H Transcript and Inhibit Osteogenic Differentiation.
    Maruyama R, Nguyen Q, Roshmi RR, Touznik A, Yokota T.
    Nucleic Acid Ther; 2022 Jun 16; 32(3):185-193. PubMed ID: 35085461
    [Abstract] [Full Text] [Related]

  • 15. ACVR1R206H FOP mutation alters mechanosensing and tissue stiffness during heterotopic ossification.
    Haupt J, Stanley A, McLeod CM, Cosgrove BD, Culbert AL, Wang L, Mourkioti F, Mauck RL, Shore EM.
    Mol Biol Cell; 2019 Jan 01; 30(1):17-29. PubMed ID: 30379592
    [Abstract] [Full Text] [Related]

  • 16. ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation.
    van Dinther M, Visser N, de Gorter DJ, Doorn J, Goumans MJ, de Boer J, ten Dijke P.
    J Bone Miner Res; 2010 Jun 01; 25(6):1208-15. PubMed ID: 19929436
    [Abstract] [Full Text] [Related]

  • 17. Elevated BMP and Mechanical Signaling Through YAP1/RhoA Poises FOP Mesenchymal Progenitors for Osteogenesis.
    Stanley A, Heo SJ, Mauck RL, Mourkioti F, Shore EM.
    J Bone Miner Res; 2019 Oct 01; 34(10):1894-1909. PubMed ID: 31107558
    [Abstract] [Full Text] [Related]

  • 18. ACVR1-activating mutation causes neuropathic pain and sensory neuron hyperexcitability in humans.
    Yu X, Ton AN, Niu Z, Morales BM, Chen J, Braz J, Lai MH, Barruet E, Liu H, Cheung K, Ali S, Chan T, Bigay K, Ho J, Nikolli I, Hansberry S, Wentworth K, Kriegstein A, Basbaum A, Hsiao EC.
    Pain; 2023 Jan 01; 164(1):43-58. PubMed ID: 35442931
    [Abstract] [Full Text] [Related]

  • 19. Dysregulated BMP signaling through ACVR1 impairs digit joint development in fibrodysplasia ossificans progressiva (FOP).
    Towler OW, Peck SH, Kaplan FS, Shore EM.
    Dev Biol; 2021 Feb 01; 470():136-146. PubMed ID: 33217406
    [Abstract] [Full Text] [Related]

  • 20. AAV-Mediated Targeting of the Activin A-ACVR1R206H Signaling in Fibrodysplasia Ossificans Progressiva.
    Yang YS, Lin C, Ma H, Xie J, Kaplan FS, Gao G, Shim JH.
    Biomolecules; 2023 Sep 08; 13(9):. PubMed ID: 37759764
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.